Order Article Reprints

Dawood AF, Al Humayed S, Momenah MA, El-Sherbiny M, Ashour H, Kamar SS, ShamsEldeen AM, Haidara MA, Al-Ani B, Ebrahim HA. MiR-155 Dysregulation Is Associated with the Augmentation of ROS/p53 Axis of Fibrosis in Thioacetamide-Induced Hepatotoxicity and Is Protected by Resveratrol. Diagnostics. 2022; 12(7):1762. https://doi.org/10.3390/diagnostics12071762

Dawood, Amal F., Suliman Al Humayed, Maha A. Momenah, Mohamed El-Sherbiny, Hend Ashour, Samaa S. Kamar, Asmaa M. ShamsEldeen, Mohamed A. Haidara, Bahjat Al-Ani, and Hasnaa A. Ebrahim. 2022. "MiR-155 Dysregulation Is Associated with the Augmentation of ROS/p53 Axis of Fibrosis in Thioacetamide-Induced Hepatotoxicity and Is Protected by Resveratrol" Diagnostics 12, no. 7: 1762. https://doi.org/10.3390/diagnostics12071762

Dawood, A. F., Al Humayed, S., Momenah, M. A., El-Sherbiny, M., Ashour, H., Kamar, S. S., ShamsEldeen, A. M., Haidara, M. A., Al-Ani, B., & Ebrahim, H. A. (2022). MiR-155 Dysregulation Is Associated with the Augmentation of ROS/p53 Axis of Fibrosis in Thioacetamide-Induced Hepatotoxicity and Is Protected by Resveratrol. Diagnostics, 12(7), 1762. https://doi.org/10.3390/diagnostics12071762